deltatrials
Recruiting PHASE1 INTERVENTIONAL 3-arm NCT07227168

A Study of STRO-004 in Adults With Refractory/Recurrent Metastatic Cancer

A Phase 1 Open-Label Study to Evaluate Safety, Pharmacokinetics, and Preliminary Anti-Tumor Activity of STRO-004 in Adults With Refractory/Recurrent Metastatic Solid Tumors

Sponsor: Sutro Biopharma, Inc.

Conditions Cervical Cancer Colorectal Cancer Endometrial Cancer Esophageal Cancer Gastric Cancer Head and Neck Squamous Cell Carcinoma HNSCC Non-Small Cell Lung Cancer NSCLC Pancreatic Ductal Adenocarcinoma (PDAC) Urothelial Cancer
Interventions Pembrolizumab STRO-004
Updated 4 times since 2025 Last updated: Mar 3, 2026 Started: Nov 7, 2025 Primary completion: Dec 31, 2027 Completion: Apr 30, 2028
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE1 trial investigates Cervical Cancer and Colorectal Cancer and is currently actively recruiting participants. Sutro Biopharma, Inc. leads this study, which shows 4 recorded versions since 2025 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

~Dec 2025 – ~Jan 2026 · 31 days · monthly snapshotRecruiting~Jan 2026 – ~Feb 2026 · 31 days · monthly snapshotRecruiting~Feb 2026 – ~Mar 2026 · 28 days · monthly snapshotRecruiting~Mar 2026 – present · 4 months · monthly snapshotRecruiting

Change History

4 versions recorded

  1. Mar 2026 — Present [monthly]

    Recruiting PHASE1

  2. Feb 2026 — Mar 2026 [monthly]

    Recruiting PHASE1

  3. Jan 2026 — Feb 2026 [monthly]

    Recruiting PHASE1

  4. Dec 2025 — Jan 2026 [monthly]

    Recruiting PHASE1

    First recorded

Nov 2025

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Sutro Biopharma, Inc.
Data source: Sutro Biopharma, Inc.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations